| A meta-analysis of cytokines in major depression Y Dowlati, N Herrmann, W Swardfager, H Liu, L Sham, EK Reim, ... Biological psychiatry 67 (5), 446-457, 2010 | 5548 | 2010 |
| Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits J Glass, KL Lanctôt, N Herrmann, BA Sproule, UE Busto Bmj 331 (7526), 1169, 2005 | 1448 | 2005 |
| A meta-analysis of cytokines in Alzheimer's disease W Swardfager, K Lanctôt, L Rothenburg, A Wong, J Cappell, N Herrmann Biological psychiatry 68 (10), 930-941, 2010 | 1364 | 2010 |
| Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound N Lipsman, Y Meng, AJ Bethune, Y Huang, B Lam, M Masellis, ... Nature communications 9 (1), 2336, 2018 | 873 | 2018 |
| The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome N Herrmann, SE Black, J Lawrence, C Szekely, JP Szalai Stroke 29 (3), 618-624, 1998 | 838 | 1998 |
| Antipsychotic drug use and mortality in older adults with dementia SS Gill, SE Bronskill, SLT Normand, GM Anderson, K Sykora, K Lam, ... Annals of internal medicine 146 (11), 775-786, 2007 | 828 | 2007 |
| Medical illness and the risk of suicide in the elderly DN Juurlink, N Herrmann, JP Szalai, A Kopp, DA Redelmeier Archives of internal medicine 164 (11), 1179-1184, 2004 | 793 | 2004 |
| Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis KL Lanctôt, N Herrmann, KK Yau, LR Khan, BA Liu, MM LouLou, ... Cmaj 169 (6), 557-564, 2003 | 616 | 2003 |
| Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study A Singh, SE Black, N Herrmann, FS Leibovitch, PL Ebert, J Lawrence, ... Stroke 31 (3), 637-644, 2000 | 555 | 2000 |
| Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis CA Köhler, TH Freitas, B Stubbs, M Maes, M Solmi, N Veronese, ... Molecular neurobiology 55, 4195-4206, 2018 | 496 | 2018 |
| Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study HH Feldman, S Ferris, B Winblad, N Sfikas, L Mancione, Y He, S Tekin, ... The Lancet Neurology 6 (6), 501-512, 2007 | 462 | 2007 |
| Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies KSP Lai, CS Liu, A Rau, KL Lanctôt, CA Köhler, M Pakosh, AF Carvalho, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (10), 876-882, 2017 | 441 | 2017 |
| The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations Z Ismail, L Agüera-Ortiz, H Brodaty, A Cieslak, J Cummings, CE Fischer, ... Journal of Alzheimer’s disease 56 (3), 929-938, 2017 | 436 | 2017 |
| Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study SS Gill, PA Rochon, N Herrmann, PE Lee, K Sykora, N Gunraj, ... Bmj 330 (7489), 445, 2005 | 424 | 2005 |
| Antidepressants for agitation and psychosis in dementia DP Seitz, N Adunuri, SS Gill, A Gruneir, N Herrmann, P Rochon Cochrane Database of Systematic Reviews, 2011 | 414 | 2011 |
| Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe LK Tremblay, CA Naranjo, SJ Graham, N Herrmann, HS Mayberg, ... Archives of general psychiatry 62 (11), 1228-1236, 2005 | 394 | 2005 |
| Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future YE Geda, LS Schneider, LN Gitlin, DS Miller, GS Smith, J Bell, J Evans, ... Alzheimer's & dementia 9 (5), 602-608, 2013 | 387 | 2013 |
| The effect of exercise training on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF): a meta-analysis A Dinoff, N Herrmann, W Swardfager, CS Liu, C Sherman, S Chan, ... PloS one 11 (9), e0163037, 2016 | 377 | 2016 |
| The effect of acute exercise on blood concentrations of brain‐derived neurotrophic factor in healthy adults: a meta‐analysis A Dinoff, N Herrmann, W Swardfager, KL Lanctot European Journal of Neuroscience 46 (1), 1635-1646, 2017 | 365 | 2017 |
| Current and emerging drug treatment options for Alzheimer’s disease: a systematic review N Herrmann, SA Chau, I Kircanski, KL Lanctot Drugs 71, 2031-2065, 2011 | 330 | 2011 |
